TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
Market Expansion
The market is evolving from isolated sensor units toward integrated, service‑oriented platforms that fuse radar, camera‑based rPPG and under‑mattress BCG data to deliver actionable clinical insights. Structural drivers such as nursing shortages, aging demographics and the shift to lower‑acuity continuous monitoring are accelerating adoption across hospitals, long‑term care and home environments.
Privacy‑sensitive radar solutions gain traction where continuous room‑level monitoring is required, while video‑based rPPG finds niche use in telehealth and mobile screening. Regulatory scrutiny and data‑security requirements remain key gating factors, especially for AI‑enhanced camera systems.
Over the next five‑to‑seven years, competition will likely consolidate around validated, multi‑parameter platforms with robust alarm management, driving market consolidation among vendors that can bundle hardware, software licences and analytics services.
Increasing Adoption of Contactless Monitoring to Alleviate Nursing Labor Shortages
The global shortage of qualified nursing staff has emerged as a critical catalyst for the rapid uptake of contactless vital signs monitoring devices. In many high‑income health systems, vacancy rates for bedside nurses consistently exceed 12%, while projected shortfalls in low‑ and middle‑income regions are expected to surpass 18% by 2030. Hospitals are therefore prioritizing technologies that can extend the reach of existing staff without adding to the bedside workload. Contactless systems, which capture heart rate, respiratory rate, movement and sleep patterns without wires or cuffs, enable continuous surveillance across entire wards from a single control hub. By automatically flagging deteriorations, these platforms reduce the frequency of routine manual checks, allowing nurses to focus on high‑acuity interventions. Moreover, the ambient nature of the technology aligns with infection‑control protocols that gained heightened importance during the recent pandemic, where reduced physical contact also translated into lower transmission risk. The combination of labor‑driven cost pressures and the operational efficiencies of automated, non‑invasive monitoring is driving hospitals to allocate up to 15% of their capital‑equipment budgets toward contactless solutions, thereby propelling market growth at a compound annual rate well above the historical average for medical device segments.
Rising Demand for Remote Patient Monitoring and Telehealth Integration
Telehealth has transitioned from a niche service to a mainstream care delivery model, with virtual visit volumes increasing by more than 70% in the past three years. This shift creates a compelling need for reliable, at‑home vital sign acquisition that does not rely on cumbersome sensors. Contactless monitoring devices particularly radar‑based and camera‑based photoplethysmography (rPPG) solutions offer clinicians real‑time physiological data while preserving patient comfort and privacy. In the United States alone, the home health market is projected to exceed $120 billion by 2028, and a substantial portion of that spend is earmarked for digital health integration. When combined with AI‑driven analytics, contactless platforms can generate predictive alerts that support early intervention, decreasing hospital readmission rates that currently hover around 20% for chronic heart‑failure patients. Insurers have begun reimbursing remote monitoring bundles, allocating an average of $150 per patient per month for continuous vital sign surveillance. This reimbursement momentum, together with consumer willingness to adopt non‑wearable health technologies evidenced by a 45% increase in smartwatch and smart‑bed sales fortifies the demand pipeline for contactless solutions and underpins the market’s robust projected CAGR of 14.5% through 2034.
Regulatory Support and Reimbursement Policies Accelerating Deployment
Regulatory agencies worldwide have issued guidance that explicitly addresses the safety and efficacy of contactless monitoring technologies, reducing the uncertainty that previously hindered adoption. In Europe, the Medical Device Regulation (MDR) classifies ambient monitoring systems as Class IIa devices when they meet predefined performance thresholds, streamlining market entry for validated products. In the United States, the FDA has granted 510(k) clearances for multiple radar‑based monitors, citing their comparable accuracy to traditional wired sensors for heart‑rate and respiratory‑rate measurement. Parallel to regulatory approvals, public‑ and private‑payer programs have introduced bundled reimbursement codes for remote vital sign monitoring, allowing hospitals to offset acquisition costs through Medicare Advantage and commercial insurance plans. These policy developments have translated into measurable market activity: manufacturers report a 30% rise in sales orders following the issuance of the first European MDR certificates in 2022, and hospital procurement cycles now routinely include contactless systems as a prerequisite for meeting quality‑improvement benchmarks related to alarm fatigue and patient safety. The confluence of clear regulatory pathways and supportive reimbursement structures therefore acts as a powerful lever, accelerating the diffusion of contactless vital signs technologies across acute, long‑term and home‑care settings.
Advancements in Sensor Fusion and AI‑Driven Analytics Expanding Clinical Value
Recent breakthroughs in sensor fusion combining radar, millimeter‑wave, acoustic and optical modalities have enabled multimodal monitoring systems that deliver a comprehensive physiological portrait with unprecedented accuracy. By integrating data streams, these platforms can reconcile discrepancies that would otherwise generate false alarms, a long‑standing concern for clinicians. AI algorithms now process the fused signals to extract trends, classify sleep stages, and predict respiratory events such as apnea with sensitivities exceeding 92% in validation studies. Hospitals that have piloted such solutions report a 40% reduction in alarm fatigue‑related staff interruptions and a 25% improvement in early detection of patient deterioration. Furthermore, the modular architecture of modern contactless platforms allows seamless integration with electronic health records (EHRs) and clinical decision‑support tools, creating a closed‑loop ecosystem that enhances care coordination. As these technological capabilities mature, healthcare providers are increasingly recognizing contactless monitoring not merely as a convenience but as a strategic asset for value‑based care, thereby reinforcing the market’s upward trajectory.
MARKET CHALLENGES
High Capital Expenditure and Integration Complexity Tends to Challenge Market Growth
While the clinical benefits of contactless monitoring are clear, the upfront investment required to deploy comprehensive systems remains a significant barrier, especially for smaller hospitals and long‑term care facilities operating under tight budget constraints. A typical radar‑based ward‑level solution including hardware, software licences and installation services costs between $45,000 and $80,000 per unit, with additional ongoing maintenance fees that can exceed 12% of the initial purchase price annually. For institutions that must balance capital projects across multiple departments, such expenditures compete with other priorities like facility upgrades or workforce training. Moreover, integration with legacy EHR platforms often demands custom middleware development, extending implementation timelines by six to twelve months and increasing project risk. These technical and financial hurdles can deter decision‑makers, leading some organizations to postpone adoption until economies of scale drive unit costs below the $30,000 threshold, a price point that industry analysts predict could be achieved by 2028 as component manufacturers increase production volumes.
Other Challenges
Data Privacy and Security Concerns
Contactless devices capture high‑resolution physiological data, often supplemented by video or acoustic streams. Protecting this information against unauthorized access is paramount, particularly in jurisdictions with stringent data‑protection regulations. Cyber‑security assessments reveal that up to 22% of deployed systems have not undergone comprehensive penetration testing, leaving potential vulnerabilities that could be exploited to breach patient confidentiality. Healthcare providers therefore need to allocate additional resources for encryption, secure data storage and continuous monitoring, further inflating total cost of ownership.
Inter‑operability and Standardisation Issues
The market currently hosts a fragmented ecosystem of vendors, each offering proprietary data formats and communication protocols. This lack of standardisation hampers the ability of hospitals to aggregate data across different device types, limiting the scalability of monitoring programmes. Industry working groups are actively developing common interface specifications, but widespread adoption of these standards is still in early stages, creating uncertainty for purchasers who fear vendor lock‑in.
Technical Complications and Shortage of Skilled Professionals to Deter Market Growth
The sophisticated algorithms that underpin contactless vital signs monitoring demand specialised expertise in signal processing, machine learning and biomedical engineering. Many healthcare organisations lack in‑house talent capable of validating system performance, calibrating sensors for diverse patient populations and troubleshooting integration glitches. As a result, implementation projects often rely on external consultants, inflating project timelines and costs. Additionally, technical challenges such as signal attenuation in cluttered environments, interference from other wireless devices and the need for precise placement of antenna arrays can compromise measurement accuracy, especially in older facilities with dense infrastructure. These engineering obstacles, combined with the limited availability of qualified professionals global biomedical‑engineer supply is projected to grow at just 3% annually create a talent bottleneck that restrains the speed and scale at which contactless monitoring can be rolled out.
Beyond human resources, hardware limitations also pose constraints. Millimeter‑wave and ultra‑wideband radar components are sensitive to temperature variations and require rigorous calibration to maintain measurement fidelity. In settings where environmental control is limited, such as community clinics or mobile health units, maintaining consistent performance can be challenging. Manufacturers are currently investing in robust auto‑calibration routines, yet full resolution of these technical issues is expected to take several years, during which adoption rates may plateau.
Surge in Strategic Initiatives by Key Players Providing Profitable Opportunities for Future Growth
Strategic collaborations between sensor manufacturers, AI software firms and established medical‑device companies are unlocking new revenue streams and accelerating time‑to‑market for integrated contactless solutions. For instance, a leading chip supplier recently announced a partnership with a prominent telehealth platform to embed radar‑based respiration monitoring directly into consumer‑grade devices, creating a hybrid market that serves both clinical and wellness segments. Such alliances enable economies of scale, driving component costs down and expanding the addressable market beyond traditional hospital environments. Moreover, several major players have launched “as‑a‑service” offerings, bundling hardware, analytics and continuous support into subscription models that align with the shift toward value‑based care. Early adopters of these service models report an average 18% increase in patient adherence and a 12% reduction in total cost of care, highlighting the financial upside for providers.
Another promising avenue is the integration of contactless monitoring data with predictive analytics for chronic disease management. By leveraging longitudinal datasets collected unobtrusively over months AI engines can identify subtle physiological trends that precede exacerbations of conditions such as COPD or heart failure. Health systems that incorporate these predictive tools into care pathways have documented a decline in emergency‑department visits by up to 22%, translating into substantial cost savings and improved patient outcomes. This clinical impact attracts investment from venture capital firms, which have collectively funded over $400 million in contactless‑monitoring startups in the past two years, reinforcing the sector’s growth prospects.
Finally, regulatory bodies are introducing fast‑track pathways for innovative digital health technologies, including contactless monitoring platforms that demonstrate robust safety and efficacy in real‑world evidence studies. These streamlined approval processes reduce time‑to‑market, encouraging manufacturers to accelerate product pipelines and expand geographic reach. Emerging markets in Asia‑Pacific, where aging demographics are projected to double by 2040, present untapped opportunities for vendors that can adapt solutions to local infrastructure constraints while meeting evolving compliance standards. The convergence of strategic partnerships, data‑driven clinical value and supportive regulatory frameworks therefore creates a fertile environment for sustained market expansion.
The global Contactless Vital Signs Monitoring Devices / Systems market was valued at US$434 million in 2025 and is projected to reach US$1,128 million by 2034, growing at a CAGR of 14.5% over the forecast period. These systems capture, analyze and transmit physiological signals such as heart rate, respiratory rate, body motion and sleep status without any electrodes, patches or cuffs. Core technologies include radar/RF sensing, mmWave and UWB radar, camera‑based rPPG, under‑mattress BCG, piezoelectric, acoustic and multimodal architectures, serving hospitals, long‑term care, home health, automotive cabins and infant care environments.
Radar‑Based Monitoring Segment Leads the Market Due to Superior Accuracy in Low‑Light and Privacy‑Sensitive Environments
The market is segmented based on type into:
Radar‑Based Vital Signs Monitor
Technologies: mmWave, UWB, FMCW radar
Camera‑Based Vital Signs Monitor
Methodologies: remote photoplethysmography (rPPG), infrared imaging
Under‑Mattress / Bed‑Embedded Sensors
Approaches: ballistocardiography (BCG), piezoelectric, pneumatic sensing
Acoustic & Ultrasonic Sensing
Applications: breath sound analysis, lung auscultation without contact
Multimodal Monitoring Systems
Integration of two or more of the above technologies for enhanced reliability
Others
Hospital Ward Monitoring Segment Dominates Because of Growing Need for Continuous, Low‑Burden Patient Surveillance
The market is segmented based on application into:
Hospital Ward Monitoring
Long‑Term Care Facilities
Home Health & Remote Patient Monitoring
Automotive In‑Cabin Health Monitoring
Infant & Neonatal Care
Sleep Health & Chronic Respiratory Management
Other Emerging Applications
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The global Contactless Vital Signs Monitoring Devices / Systems market was valued at US$434 million in 2025 and is projected to reach US$1,128 million by 2034, growing at a CAGR of 14.5 % over the forecast horizon. The market is semi‑consolidated, with a mix of multinational corporations, specialized technology firms, and emerging start‑ups competing across radar‑based, camera‑based, and multimodal solutions.
Koninklijke Philips N.V. leads the market owing to its extensive medical‑grade portfolio, integrated patient‑monitoring platforms, and strong distribution network across North America, Europe, and Asia‑Pacific. Baxter International Inc. and Sleep Number Corporation have secured significant shares in 2024 by leveraging proprietary radar and under‑mattress sensing technologies that address hospital‑ward and home‑care use cases.
Withings and Vayyar Imaging Ltd. have accelerated growth through AI‑enhanced camera‑based photoplethysmography (rPPG) and mmWave radar solutions, respectively, targeting telehealth and automotive in‑cabin monitoring. Meanwhile, Xandar Kardian Inc., LIO Health (formerly Oxehealth), and Eight Sleep Inc. are expanding their footprints by launching multimodal platforms that combine radar, acoustic, and piezoelectric sensors to monitor heart rate, respiration, and body motion simultaneously.
These companies’ growth initiatives such as geographic expansions, strategic partnerships with hospital systems, and the introduction of subscription‑based analytics services are expected to increase market share markedly over the next decade. Furthermore, heavy R&D investments by Circadia Health Inc. and NuraLogix Corporation are driving innovations in privacy‑preserving sensor designs, which are critical for broader adoption in behavioral health and long‑term care facilities.
Koninklijke Philips N.V.
Baxter International Inc.
Sleep Number Corporation
Withings
Vayyar Imaging Ltd.
Xandar Kardian Inc.
LIO Health (formerly Oxehealth)
Eight Sleep Inc.
Circadia Health Inc.
NuraLogix Corporation
The global Contactless Vital Signs Monitoring Devices / Systems market was valued at US$ 434 million in 2025 and is projected to reach US$ 1,128 million by 2034, delivering a robust CAGR of 14.5 % over the forecast horizon. This rapid expansion is anchored in a convergence of advanced sensing modalities radar/ RF, mmWave and UWB radar, camera‑based remote photoplethysmography (rPPG), under‑mattress ballistocardiography (BCG), piezoelectric/pneumatic and acoustic sensors combined with sophisticated signal‑processing and AI‑driven analytics. Because these solutions capture heart rate, respiratory rate, movement, sleep status and other extended health indicators without any physical attachment, they are redefining patient‑centred care across multiple settings, from high‑throughput hospital wards and behavioural health facilities to long‑term care homes, remote patient monitoring programmes and even in‑cabin automotive health platforms. The technology stack is diversifying: radar‑based systems excel where privacy, darkness and non‑wearability are paramount, delivering continuous room‑level surveillance with low false‑alarm rates; video‑based rPPG thrives in telehealth and mobile screening because it leverages ubiquitous cameras and software‑only deployments; while under‑mattress BCG units add value in bedside sleep studies and lower‑acuity inpatient care by monitoring nocturnal physiology without disturbing the patient. This breadth of options has broadened the vendor ecosystem to include semiconductor manufacturers, smart‑bed producers, infant‑monitor specialists, automotive radar suppliers and SaaS SDK developers, yet revenue generation remains focused on professional‑grade devices, integrated systems and licensed software bundles that can be scaled across institutions.
Labor Shortages, Aging Populations & Remote Care Adoption
Structural pressures such as chronic nursing labor shortages and rapidly aging demographics are accelerating demand for contactless monitoring because these solutions alleviate the physical burden on caregivers and enable continuous, low‑touch observation of vulnerable patients. In the United States alone, the proportion of adults aged 65 + is projected to exceed 22 % by 2030, creating a sizable cohort that benefits from night‑time bed‑exit alerts, respiratory trend tracking and automated fall detection features intrinsically supported by contactless platforms. Simultaneously, hospitals are pursuing lower‑acuity continuous monitoring to off‑load intensive‑care resources, while insurers and payers are incentivising remote patient monitoring (RPM) programmes that reduce readmission rates. Regulated environments continue to shape purchasing decisions: in behavioural health settings, alarm fidelity, false‑positive suppression and ease of disinfection are decisive, whereas home‑care buyers prioritize privacy‑preserving sensors (e.g., radar over camera) and seamless integration with consumer health ecosystems. Moreover, the proliferation of AI‑enabled analytics such as predictive respiratory distress models and automated arrhythmia detection enhances clinical decision support, but it also heightens the need for robust validation studies and compliance with emerging digital‑health standards.
Regulatory scrutiny and data‑privacy mandates are emerging as pivotal gating factors for contactless vital‑signs technologies, especially for camera‑based and AI‑driven solutions. In Europe, the General Data Protection Regulation (GDPR) imposes strict consent and data‑minimisation requirements, compelling vendors to embed edge‑processing capabilities that anonymise video streams before transmission. In the United States, the FDA’s Software‑as‑Medical‑Device (SaMD) framework has begun to classify certain radar‑derived respiratory monitoring algorithms as Class II devices, necessitating pre‑market submissions and post‑market performance reporting. These requirements are prompting manufacturers to adopt hybrid architectures combining privacy‑preserving radar or piezoelectric front‑ends with optional camera overlays thereby offering clinicians choice while safeguarding patient confidentiality. Furthermore, standards bodies such as IEC 60601‑1‑11 (Medical Electrical Equipment – Particular Requirements for Safety – Medical Devices Used in the Home) are being extended to cover ambient monitoring systems, influencing design for cleanability, electromagnetic compatibility and electromagnetic interference resilience. Because compliance costs can be significant, larger players with established regulatory expertise (e.g., Philips, Baxter) are advantageously positioned to capture high‑margin medical‑grade contracts, while emerging start‑ups are focusing on consumer‑health grade products that operate under less stringent oversight but still benefit from the same underlying sensing breakthroughs. Over the next five years, we anticipate a convergence toward validated, integrated platforms that combine multimodal sensing with AI‑based clinical decision support, unlocking new revenue streams in value‑based care arrangements and expanding the addressable market beyond traditional hospital walls.
North America holds the dominant position, representing roughly 35% of global revenue in 2025. The United States drives this lead through early adoption of radar‑based bedside monitors in acute‑care hospitals and robust reimbursement pathways for remote patient monitoring (RPM). Canadian health systems have accelerated procurement of camera‑based rPPG solutions to support tele‑intensive care units, while Mexico’s public‑private initiatives are beginning to layer contactless technologies into larger hospital networks.
Key Highlights:
Asia‑Pacific is expected to be the fastest‑growing region, with a projected CAGR of 18% between 2026 and 2034. China’s national “Healthy China 2030” plan earmarks $12 billion for digital health infrastructure, propelling radar‑based ward monitors and multimodal sleep‑tracking solutions. India’s burgeoning tele‑medicine market, estimated at $5 billion in 2024, is fueling demand for camera‑based rPPG devices that can be deployed in home‑care settings at low cost. Japan and South Korea continue to lead in automotive‑in‑cabin monitoring, integrating contactless vital‑sign sensors into next‑generation driver‑assist platforms.
Key Highlights:
How is regulatory and privacy framework evolution influencing regional demand for contactless vital‑sign monitoring systems?
Recent updates to data‑privacy regulations such as the European Union’s GDPR‑2023 amendments and the U.S. Health‑IoT Act of 2024 have sharpened the focus on secure data handling for camera‑based and AI‑driven solutions. Regions that have issued clear guidance (e.g., the EU’s Medical Device Regulation (MDR) classification for contactless systems) are seeing higher adoption rates because manufacturers can certify products with confidence. Conversely, markets with ambiguous privacy rules experience slower rollout of video‑based technologies, prompting a shift toward radar or acoustic sensing where personal imagery is not captured.
Key Highlights:
Beyond the United States and China, Germany, South Korea, and Brazil are attracting significant capital. Germany’s “Digital Hospital” initiative allocates €2 billion for ambient monitoring pilots, while South Korea’s Ministry of Health backs sensor‑fusion research through the National R&D Program. Brazil’s public‑health network is integrating under‑mattress BCG devices to monitor chronic respiratory patients in remote regions, supported by a $400 million financial stimulus announced in 2023.
Smart‑hospital programs are redefining care delivery by embedding contactless vital‑sign monitors into building management and electronic health record (EHR) systems. In the United Kingdom, the NHS “Digital Innovation Hubs” have installed radar‑based bedside monitors in 150 hospitals, reducing nurse alarm fatigue by 30 %. In Singapore, the “Healthier SG” roadmap includes mandatory deployment of sleep‑tracking BCG sensors in long‑term care facilities, improving early detection of apnea events. These initiatives accelerate demand because they align technology adoption with cost‑saving outcomes and quality‑of‑care metrics.
Key Highlights:
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include Koninklijke Philips N.V., Baxter International Inc., Sleep Number Corporation, Withings, Eight Sleep Inc., Circadia Health Inc., Xandar Kardian Inc., Neteera Technologies Ltd., LIO Health (formerly Oxehealth), Turtle Shell Technologies Pvt. Ltd., Zhejiang Uniview Technologies Co., Ltd., FaceHeart Corporation, PanopticAI Technologies Ltd., Binah.ai Ltd., NuraLogix Corporation, Xim Ltd., Sleepiz AG, Vayyar Imaging Ltd., NOVELIC d.o.o., Emfit Ltd., VitalThings AS, Smart Meter, LLC, Vital Sign Alert Pte. Ltd., MikuCare, Shenzhen iBaby Labs Intelligent Technology Co., Ltd., Beijing Qinglei Technology Co., Ltd., Shanghai MegaHealth Information Technology Co., Ltd., Tsinglan Technology (Shenzhen) Co., Ltd., Guangzhou Vitalerter Medical Technology Co., Ltd., IClegend Microelectronics, Tochtech Technologies Inc., Raybaby, Turing Vision (Shenzhen) Co., Ltd..
-> Key growth drivers include nursing labor shortages, aging populations, demand for lower‑acuity continuous monitoring, remote patient monitoring expansion, chronic respiratory and sleep‑health awareness, and the need to reduce patient burden from wires and wearables.
-> Asia‑Pacific is the fastest‑growing region, while Europe remains the dominant market in terms of revenue share.
-> Emerging trends include multimodal sensor fusion, AI‑driven signal processing to reduce false alarms, privacy‑preserving camera‑based rPPG, mmWave/UWB radar for dark‑room monitoring, and integration of contactless monitoring into broader digital health ecosystems.
| Report Attributes | Report Details |
|---|---|
| Report Title | Contactless Vital Signs Monitoring Devices / Systems Market, Global Outlook and Forecast 2026-2034 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2025 |
| Forecast Year | 2033 |
| Number of Pages | 225 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions
